INTEGRA Biosciences welcomes Line Stigen Raquet as a non-executive board member, bringing over 20 years of leadership experience in the life sciences sector. Line, a biochemist, has a strong foundation for success as an entrepreneur and has demonstrated competency in commercial and P&L functions at major industry players. She has been CEO of several companies, including Creoptix AG and Nanolive SA, and her appointment follows the resignation of Elmar Morscher. Elmar, a key figure in INTEGRA’s success, has stepped down after transforming the company into a leading international manufacturer of liquid handling solutions. Line aims to build on Elmar’s legacy and contribute to furthering INTEGRA’s goals of accelerating scientific discoveries.
Source link
INTEGRA Biosciences announces the appointment of a new board member
